Cargando…
Rapid molecular test (SeptiFast(®)) reduced time for adjustment of antibiotic treatment in comparison with conventional blood cultures in critically ill sepsis patients: a randomized controlled clinical trial (preliminary results)
Autores principales: | Rodrigues, Cristhieni, dos Santos, Mirlane Silva, Filho, Helio Hehl Caiaffa, Charbel, Cecilia Eugênia, da Silva, Luciane de Carvalho Sarahyba, Rossi, Flávia, Franco, Maria Renata Gomes, Siciliano, Rinaldo Focaccia, Strabelli, Tânia Mara Varejão |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952475/ http://dx.doi.org/10.1186/cc12926 |
Ejemplares similares
-
The effect of a rapid molecular blood test on the use of antibiotics for nosocomial sepsis: a randomized clinical trial
por: Rodrigues, Cristhieni, et al.
Publicado: (2019) -
LightCycler SeptiFast in early diagnosis of sepsis: our experience
por: Raineri, SM, et al.
Publicado: (2009) -
Evaluation of the Light-Cycler® SeptiFast Test in Newborns With Suspicion of Nosocomial Sepsis
por: Ortiz Ibarra, Javier, et al.
Publicado: (2015) -
SeptiFast for diagnosis of sepsis in severely ill patients from a Brazilian hospital
por: Sitnik, Roberta, et al.
Publicado: (2014) -
Rapid Qualitative Urinary Tract Infection Pathogen Identification by SeptiFast(®) Real-Time PCR
por: Lehmann, Lutz E., et al.
Publicado: (2011)